516466-33-4(N-Cyclopentyl-4-pyrimidin-2-ylpiperazine-1-carbothioamide)

516466-33-4 Basic information More..

Product Name:	N-Cyclopentyl-4-pyrimidin-2-ylpiperazine-1-carbothioamide
Synonyms:	TOSLAB 864546;1-Piperazinecarbothioamide, N-cyclopentyl-4-(2-pyrimidinyl)-;N-Cyclopentyl-4-pyrimidin-2-ylpiperazine-1-carbothioamide
CAS:	516466-33-4
MF:	C14H21N5S
MW:	291.42
EINECS:
Mol File:	Mol File

Information Error Report

Your Email:

Browse by Nationality 516466-33-4 Suppliers

Finland(1)

Russia(2)

All(3)

516466-33-4 Recommend Suppliers

Recommend You Select Member Companies.

Company Name:	VITAS-M LABORATORY, LTD. Recommend Complaint
Tel:	+7 495 939 48 31
Email:
Nationality:	Russia
Products Intro:	Product Name:N-cyclopentyl-4-(pyrimidin-2-yl)piperazine-1-carbothioamide CAS:516466-33-4 Purity:90%+ Package:1mg
CB Index:	64
WebSite:	www.vitasmlab.com
Related Information:	Sales Network Catalog(6752) User Evaluation

Company Name:	Interbioscreen Ltd. Recommend Complaint
Tel:	+7 (49) 6524-0091
Email:	screen@ibscreen.chg.ru
Nationality:	Finland
Products Intro:	CAS:516466-33-4 Purity:95% Package:1mg Remarks:C14H21N5S
CB Index:	60
WebSite:	www.ibscreen.com
Related Information:	Sales Network Catalog(6169) User Evaluation

Company Name:	Technology for Organic Synthesis Laboratory TOSLab Recommend Complaint
Tel:	[7] 3433754135
Email:
Nationality:	Russia
Products Intro:
CB Index:	69
WebSite:	www.toslab.com
Related Information:	Sales Network Catalog(6063) User Evaluation

Tag: 516466-33-4

HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.